758O - Selinexor (Kpt-330), an Oral, Selective Inhibitor of Nuclear Export (Sine) Shows Anti-Prostate Cancer (Prca) Activity Preclinically & Disease Control in Patients (Pts) with Chemotherapy Refractory, Castrate-Resistant Prostate Cancer (Crpc)

Autor: Mahaseth, H., Maity, S.N., Gabrail, N.Y., Mahipal, A., Gericitano, J.F., Shacham, S., Rashal, T., Klebanov, B., Carlson, R., Shacham, E., Vincent, D., Kauffman, M., Shields, A.F., Mirza, M.R., Araujo, J.C.
Zdroj: In Annals of Oncology September 2014 25 Supplement 4:iv257-iv257
Databáze: ScienceDirect